Longeveron Inc. — Investor Relations & Filings
Longeveron Inc. is a clinical-stage biotechnology company that develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product, laromestrocel (Lomecel-B™), is a cell-based therapy designed to repair, regenerate, and restore damaged tissue. Longeveron's clinical development is focused on several key indications, including Hypoplastic Left Heart Syndrome (HLHS), a rare congenital heart defect in infants for which it has an orphan drug designation. Other primary clinical programs target Alzheimer's disease and Aging Frailty. For its Alzheimer's program, the U.S. FDA has granted laromestrocel both Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations. The company's research aims to improve healthspan by addressing unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS | 2026-05-20 | English | |
| DEFINITIVE ADDITIONAL MATERIALS | 2026-05-20 | English | |
| PROXY STATEMENT | 2026-05-20 | English | |
| 10-Q - Longeveron Inc. (0001721484) (Filer) | 2026-05-13 | English | |
| 424B3 - Longeveron Inc. (0001721484) (Filer) | 2026-04-17 | English | |
| 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691597 | ARS | 2026-05-20 | English | ||
| 46691649 | DEFINITIVE ADDITIONAL MATERIALS | 2026-05-20 | English | ||
| 46691779 | PROXY STATEMENT | 2026-05-20 | English | ||
| 45759933 | 10-Q - Longeveron Inc. (0001721484) (Filer) | 2026-05-13 | English | ||
| 34662335 | 424B3 - Longeveron Inc. (0001721484) (Filer) | 2026-04-17 | English | ||
| 34028758 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English | ||
| 34026781 | S-1 - Longeveron Inc. (0001721484) (Filer) | 2026-04-10 | English | ||
| 33042625 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-03-25 | English | ||
| 33040616 | D - Longeveron Inc. (0001721484) (Filer) | 2026-03-25 | English | ||
| 33034971 | 8-K - Longeveron Inc. (0001721484) (Filer) | 2026-03-24 | English | ||
| 32897265 | 8-K - LONGEVERON INC. (0001721484) (Filer) | 2026-02-13 | English | ||
| 31462769 | SCHEDULE 13G/A Filing | 2026-02-10 | English | ||
| 13071948 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
| 13071949 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
| 13071950 | PRIMARY DOCUMENT | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Longeveron Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35052/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35052 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35052 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35052 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35052}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Longeveron Inc. (id: 35052)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.